Searched for
TORRENT CIPLA DEAL
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...- Torrent Pharma keen to break into big leagueTorrent Pharma, currently seventh in India, is aimingto break into the top three drugmakers within five years through strategic acquisition...
- Cipla promoters sell 2.53% stake for around Rs 2,600 crorePromoters of Cipla, including Person Acting in Concert, sold 2.04 crore shares in a block deal worth around Rs 2,600 crore to create liquid...
- Cipla promoters to sell up to 2.53% for Rs 2,637 croreThe move, days after the company posted its best annual results, has triggered speculation that more such transactions could be in the offi...
- Promoter group entities likely to sell 2.5% stake in Cipla worth Rs 2,637 crore via block deals: ReportThe price range of the block is fixed at Rs 1,289-1,357, taking the total deal value to around Rs 2,637 crore.
- Torrent talks for $7 billion Cipla buyout trip on valuationTorrent Pharma's attempt to acquire the stake of the Hamied family in Cipla has hit a roadblock due to differences in valuation. Talks betw...
- Torrent Pharma Q2 Results: Profit rise on strong demandConsolidated net profit was 3.86 billion rupees ($46.4 million) for the quarter ended Sept. 30, compared with 3.12 billion rupees a year ea...
- Cipla stake sale plan faces hurdle as promoters differ on valuation: ReportCipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute amo...
- 3 stocks Nithya Balasubramanian is bullish on from pharma sectorWe have seen some players recall some products. We have seen some players file bankruptcies. So these will therefore create opportunities f...
- Torrent in talks with Apollo to borrow up to $1 billion for Cipla bid, sources sayTorrent has also been in talks with CVC Capital Partners and Bain Capital who might become equity partners in a consortium and contribute a...
- Torrent Pharma looks to tie up with CVC Capital to fund Cipla purchaseTorrent Pharmaceuticals is in advanced talks with CVC Capital Partners to raise at least $1.2-1.5 billion for its proposed acquisition of r...
- Why Torrent Pharma is ready to go ahead with the daunting Cipla dealAhmedabad-based Torrent Pharma is seeking financing for a deal with Indian pharmaceutical company Cipla. Torrent Pharma is interested in bu...
- Hot Stocks: Brokerage view on Torrent Pharma, RIL, Voltas and PaytmNomura maintained a buy rating on Torrent Pharma but raised the target to Rs 2199 from Rs 1838 earlier. The potential acquisition of Cipla ...
- Bain dials Dr Reddy's Laboratories to team up for joint Cipla bidPrivate equity firm Bain Capital has approached Indian pharmaceutical company Dr Reddy's Laboratories (DRL) to explore a joint bid for the ...
- Torrent Pharma says it has no disclosure to make now on potential Cipla stake buy deal reportsTorrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the com...
- Torrent in top gear to close out Cipla buyout, in talks with PEs, banks for fundsRival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar. Torrent taps PE funds like Warburg Pincus, CVC among othe...
- 4+1 stocks that Dipan Mehta would keep in his 5-year-plus basket"Whenever we have seen a change of management like this, it has worked positively for shareholders. Look at what happened in JB Chemicals, ...
- Torrent joins fray for Hamied family stake in Cipla, up against Blackstone and Baring PETorrent Pharma is reportedly vying to acquire the Hamied family's stake in Cipla, which could become the largest pharmaceutical deal since ...
- Cipla, JB Chemicals, Torrent lead Rs 4,500-crore race for Medley PharmaSet up in 1969 by Sami Khatib as Medley Laboratories, the Mumbai-based privately held company, now called Medley Pharmaceuticals, ranks amo...
- Buy Lupin, Aurobindo Pharma, Biocon in pharma space: Sonam UdasiEven Cipla is a laggard but then there is a potential there that valuations are attractive and at some point it should turnaround.
Load More
